Suppr超能文献

补体介导的免疫复合物疾病患者免疫沉淀抑制作用

Complement-mediated inhibition of immune precipitation in patients with immune complex diseases.

作者信息

Naama J K, Mitchell W S, Zoma A, Veitch J, Whaley K

出版信息

Clin Exp Immunol. 1983 Feb;51(2):292-8.

Abstract

The ability of human sera to prevent the precipitation of antigen-antibody complexes has been investigated. The early complement components including C3 are required for optimal prevention of immune precipitation, whereas the later components are not required. The sera of 36 of 75 patients with seropositive rheumatoid arthritis (RA), 14 of 32 with SLE and four of 17 with glomerulonephritis exhibited reduced capacities to prevent immune precipitation. In contrast sera from patients with seronegative RA, ankylosing spondylitis, psoriatic arthritis or degenerative joint disease were normal in this respect. In SLE and GN sera hypocomplementaemia was frequently associated but not always with failure to prevent immune precipitation, whereas only a small proportion of the patients with seropositive RA and reduced capacity to retain complexes in a soluble form were hypocomplementaemic. Thus the failure of sera to prevent the precipitation of antigen-antibody complexes is not always associated with hypocomplementaemia.

摘要

已对人血清阻止抗原-抗体复合物沉淀的能力进行了研究。早期补体成分(包括C3)是最佳阻止免疫沉淀所必需的,而后期成分则不需要。75例血清反应阳性类风湿性关节炎(RA)患者中的36例、32例系统性红斑狼疮(SLE)患者中的14例以及17例肾小球肾炎患者中的4例,其血清阻止免疫沉淀的能力降低。相比之下,血清反应阴性的RA、强直性脊柱炎、银屑病关节炎或退行性关节病患者的血清在这方面是正常的。在SLE和肾小球肾炎患者血清中,补体减少症经常出现,但并不总是与无法阻止免疫沉淀相关,而血清反应阳性的RA患者中,只有一小部分以可溶形式保留复合物能力降低的患者存在补体减少症。因此,血清无法阻止抗原-抗体复合物沉淀并不总是与补体减少症相关。

相似文献

引用本文的文献

本文引用的文献

1
Precise standardization of reagents for complement fixation.补体结合反应试剂的精确标准化
Am J Trop Med Hyg. 1963 Jan;12:103-16. doi: 10.4269/ajtmh.1963.12.103.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验